二氮嗪预处理对小鼠肝移植缺血—再灌注损伤的保护作用及其机制研究
|
摘要
目的:
一、研究二氮嗪预处理对肝细胞缺氧-复氧后Bcl-2蛋白表达及细胞凋亡的影响,探讨二氮嗪对肝细胞缺氧-复氧损伤的保护作用及其可能机制。
二、摸索小鼠肝移植动物模型中应用RNA干扰技术沉默Bcl-2基因表达的方法。
三、研究二氮嗪预处理对小鼠肝移植缺血-再灌注损伤的保护作用及其与凋亡调控相关的可能机制。
方法:
1.建立小鼠肝细胞缺氧-复氧损伤模型,细胞随机分为A组(缺氧-复氧损伤组),B组(二氮嗪预处理组)和C组(正常对照组),分别于细胞缺氧-复氧损伤后6h、12h、24h、48h、72h 5个时相点采集标本,检测肝细胞缺氧-复氧后细胞培养液中谷丙转氨酶(ALT)、谷草转氨酶(AST)浓度,肝细胞Bcl-2 mRNA和蛋白表达及肝细胞凋亡率变化。
2.建立小鼠同种异体原位肝移植模型,根据冷保存的时间随机分为A组(冷保存4h组),B组(冷保存8h组),C组(冷保存12h组),通过各组小鼠移植术后14d存活情况做生存曲线分析;建立小鼠肝移植RNA干扰模型,利用化学合成Bcl-2基因的SiRNA,经门静脉高压注射途径导入供体肝脏。动物分为D组(供肝导入Bcl-2SiRNA组),E组(供肝导入Bcl-2SiRNA 6h肝脏移植组),F组(供肝导入Bcl-2SiRNA 24h肝脏移植组)和G组(正常对照组)。D组、E组、F组内分别设导入non-sence siRNA组为阴性对照。D组于SiRNA导入后6h、24h、48h、72h4个时相点采集标本,E组、F组和G组于移植术后24h采集标本,采用实时荧光定量PCR的方法检测Bcl-2mRNA表达变化。
3.供肝导入Bcl-2SiRNA 24h摘取供肝建立小鼠肝移植RNA干扰模型,动物分为A组(冷保存2h肝移植组)、B组(供肝导入Bcl-2 SiRNA 24h冷保存2h移植组)、C组(二氮嗪预处理冷保存2h肝移植组)、D组(供肝导入Bcl-2 SiRNA 24h二氮嗪预处理冷保存2h肝移植组)和E组(供肝导入non-sence SiRNA24h冷保存2h移植组)。每组小鼠6只,移植术后24h采集标本,检测肝移植术后肝细胞病理形态学改变、血清中谷丙转氨酶(ALT)、谷草转氨酶(AST)浓度,肝组织Bcl-2 mRNA和蛋白表达及肝细胞凋亡率变化。
结果:
1.在小鼠肝细胞缺氧-复氧损伤模型中,A、B组细胞培养液中ALT、AST浓度与C组比较明显升高(P<0.01) ,A、B两组之间比较,细胞培养液中ALT、AST浓度在缺氧-复氧6h差异无统计学意义(P>0.05),12h、24h、48h和72h B组ALT、AST浓度明显低于A组(P<0.01)。A、B组肝细胞凋亡率均高于C组( P < 0.01),A、B两组之间比较,肝细胞凋亡率在缺氧-复氧6h差异无统计学意义(P>0.05),12h、24h、48h和72h B组肝细胞凋亡率明显低于A组(P<0.01)。肝细胞Bcl-2mRNA和蛋白表达,A组和C组中均较低,两组之间比较差异无统计学意义(P>0.05),B组中Bcl-2mRNA和蛋白表达明显高于A、C组,缺氧-复氧损伤6h、12h、24h、48h和72h B组与A组比较差异存在统计学意义( P <0.01)。
2.在小鼠肝移植模型中,A组术后生存率明显高于B组和C组。在小鼠肝移植RNA干扰模型中,D组Bcl-2mRNA表达量在6h开始明显下降,24h达到高峰,持续到72h,6h、24h、48h和72h Bcl-2mRNA表达较正常对照组分别减少36.0%、66.2%、61.8%、58.1%。E组小鼠肝脏组织中Bcl-2mRNA表达较G组减少33.3%,F组较G组减少58.9%,F组与E组两组之间比较,F组肝脏组织中Bcl-2mRNA表达较E组减少38.1% ,两组之间差异有统计学意义(P<0.05)。
3.在二氮嗪预处理小鼠肝移植实验中,C组Bcl-2 mRNA和蛋白表达水平较A组明显增高(P<0.01),Bcl-2mRNA和蛋白表达分别增加2.6倍和5.1倍;B组Bcl-2 mRNA和蛋白表达水平较A组明显降低(P<0.01),Bcl-2mRNA和蛋白表达分别被抑制57.1%和83.4%;D组Bcl-2 mRNA和蛋白表达水平较A组明显降低(P<0.01),Bcl-2mRNA和蛋白表达分别减少53.3%和67.6%;B组与D组两组之间比较Bcl-2 mRNA和蛋白表达水平差异无统计学意义(P>0.05)。C组中肝细胞病理损伤程度、凋亡指数、血清AST、ALT含量明显低于各组。B组和D组中肝细胞病理损伤程度、凋亡指数、血清AST、ALT含量明显高于各组。在各组中Bcl-2表达量与缺血再灌注损伤程度和肝细胞凋亡指数呈负相关。
结论:
1.二氮嗪预处理能通过抑制肝细胞凋亡,起到保护肝细胞缺氧-复氧损伤的作用,其保护机制可能与上调Bcl-2表达有关。
2.采用门静脉高压注射途径向肝脏导入Bcl-2 siRNA 24h后摘取供肝的方法建立肝移植模型,能在小鼠肝移植体内实现Bcl-2基因的有效沉默。
3.二氮嗪预处理可能通过诱导Bcl-2表达,抑制肝细胞凋亡,从而减轻小鼠肝移植缺血-再灌注损伤。
Objectives:
1. To investigate the impact of diazoxide preconditioning on the expression of Bcl-2 in liver cell and apoptosis during hypoxia-reoxygenation injury.
2. To silence the expression of Bcl-2 gene by delivery of synthetic Bcl-2 siRNA in mice orthotopic liver transplantation model.
3. To explore the effect of diazoxide preconditioning on attenuation ischemia- reperfusion injury in mice liver graft and to study the possible mechanism relating to apoptosis .
Methods:
1. The cultured hepatocytes were randomly divided into three groups with 6 cases each : groupA (anoxia -reoxygenation group) , groupB (diazoxide preconditioning group) and groupC (control group) . Samples were collected at 6h、12 h、24 h、48h and 72h after anoxia -reoxygenation . ALT、AST levels in nutritive medium were detected. Cell apoptosis were observed by TUNEL. The expressions of Bcl-2 gene and protein level were determined by RT-PCR and Western blot.
2. Orthotopic liver transplantations in mice were performed , mice were randomly divided into three groups namely:group A (cold preservation of 4h), group B (cold preservation of 8h)and group C (cold preservation of 12h) ,the survival ratio of each group was analysised 14days after operation. The Bcl-2 gene was silenced in liver graft mice by RNAi.Synthetic Bcl-2 siRNA sequence was delivered in vivo by using a‘‘hydrodynamic’’transfection method.siRNA sequence was delivered into the portal vein with a 29-G needle. Mice were randomly divided into four groups namely: group D (donor group), group E (liver transplantation group after Bcl-2 siRNA sequence was delivered in donor 6h), group F (liver transplantation group after Bcl-2 siRNA sequence was delivered in donor 24h) and group G (control group). Samples in group D (donor group) were collected at 6h、24h、48h and 72h after Bcl-2 siRNA sequence was delivered. Samples in groupE、F、G were collected after liver transplantation 24h . The expression of Bcl-2 gene level was determined by RT-PCR.
3. Orthotopic liver transplantations in mice were performed after Bcl-2 siRNA sequence was delivered in donor 24h, mice were randomly divided into five groups namely: groupA(the liver transplantation group),group B(Bcl-2 SiRNA sequence delivery liver transplantation group),group C(diazoxide preconditioning liver transplantation group), groupD(diazoxide preconditioning and Bcl-2 SiRNA sequence delivery liver transplantation group )and groupE(non-sense SiRNA sequence delivery liver transplantation group ).24h after liver transplantation, The pathological changes of liver tissue and the serum AST、ALT level were observed in each group .Cell apoptosis were observed by TUNEL.The expression of Bcl-2 gene and protein level were determined by RT-PCR and Western blot.
Results:
1.In the cultured hepatocytes ,the cell apoptosis index and the levels of AST、ALT in nutritive medium in group A、B were significantly higher than in group C (p<0.01), the cell apoptosis index and the levels of AST、ALT in nutritive medium in group B were significantly lower than in group A (p<0.01); The expression of Bcl-2 gene and protein level in group B were significantly higher than group A、C (p<0.01).
2. In the Orthotopic liver transplantation groups,the survival ratio of group A was higher than in group B、C after liver transplantation 14d(p<0.01).In the RNAi groups , the expression of Bcl-2 mRNA in group D was decreased gradually at 6h after siRNA sequence delivery, arrived on the top at 24h and continued to decrease at 72h . The expression of Bcl-2 mRNA in group D was inhibited 36.0%、66.2%、61.8%、58.1%respectively ,at 6h、24 h、48h and 72h after Bcl-2 siRNA sequence delivery. The expression of Bcl-2 mRNA in group E and F was decreased 33.3% and 58.9%, respectively ,compared with group G. The expression of Bcl-2 mRNA existed significant difference between group E and group F, The expression of Bcl-2 mRNA in group F was decreased 38.1% compared with group E.
3.In the diazoxide preconditioning liver graft groups, the levels of Bcl-2 mRNA and protein in group C were remarkably higher than group A (p<0.01). The expression of Bcl-2 in group C was improved by 2.6-fold and 5.1-fold, compared with group A, respectively at mRNA and protein levels. The levels of Bcl-2 mRNA and protein in group B were remarkably lower than group A (p<0.01),the expression of mRNA and protein were inhibited 65.7% and 83.4%,respectively. The levels of Bcl-2 mRNA and protein in group D were remarkably lower than group A (p<0.01),the expression of mRNA and protein were decreased 53.3% and 67.6%,respectively. There was no statistical difference of Bcl-2 mRNA and protein levels between group B and group D (p>0.05). The pathological injure degree of liver tissue、apoptosis index and the serum AST、ALT levels in group C were significantly lower than other groups; The pathological injure degree of liver tissue、apoptosis index and the serum AST、ALT levels in group B、D were significantly higher than other groups; There found negative correlation between expression of Bcl-2 and the degree of ischemia- reperfusion injury as well as hepatocyte apoptosis index in each group.
Conclusions:
1. Diazoxide preconditioning can attenuate the apoptosis of hepatocytes induced by anoxia -reoxygenation ,and the protective effect may be related to the expression of Bcl-2.
2. The method of liver transplantation was operated 24h after siRNA sequence was delivered into the portal vein of donor can realize Bcl-2 gene silencing in vivo of liver graft mice.
3. Diazoxide preconditioning can protect against ischemia-reperfusion injury in liver graft mice,with its possible mechanism of upregulating the expression of Bcl-2 and prohibiting hepatocyte apoptosis.
一、研究二氮嗪预处理对肝细胞缺氧-复氧后Bcl-2蛋白表达及细胞凋亡的影响,探讨二氮嗪对肝细胞缺氧-复氧损伤的保护作用及其可能机制。
二、摸索小鼠肝移植动物模型中应用RNA干扰技术沉默Bcl-2基因表达的方法。
三、研究二氮嗪预处理对小鼠肝移植缺血-再灌注损伤的保护作用及其与凋亡调控相关的可能机制。
方法:
1.建立小鼠肝细胞缺氧-复氧损伤模型,细胞随机分为A组(缺氧-复氧损伤组),B组(二氮嗪预处理组)和C组(正常对照组),分别于细胞缺氧-复氧损伤后6h、12h、24h、48h、72h 5个时相点采集标本,检测肝细胞缺氧-复氧后细胞培养液中谷丙转氨酶(ALT)、谷草转氨酶(AST)浓度,肝细胞Bcl-2 mRNA和蛋白表达及肝细胞凋亡率变化。
2.建立小鼠同种异体原位肝移植模型,根据冷保存的时间随机分为A组(冷保存4h组),B组(冷保存8h组),C组(冷保存12h组),通过各组小鼠移植术后14d存活情况做生存曲线分析;建立小鼠肝移植RNA干扰模型,利用化学合成Bcl-2基因的SiRNA,经门静脉高压注射途径导入供体肝脏。动物分为D组(供肝导入Bcl-2SiRNA组),E组(供肝导入Bcl-2SiRNA 6h肝脏移植组),F组(供肝导入Bcl-2SiRNA 24h肝脏移植组)和G组(正常对照组)。D组、E组、F组内分别设导入non-sence siRNA组为阴性对照。D组于SiRNA导入后6h、24h、48h、72h4个时相点采集标本,E组、F组和G组于移植术后24h采集标本,采用实时荧光定量PCR的方法检测Bcl-2mRNA表达变化。
3.供肝导入Bcl-2SiRNA 24h摘取供肝建立小鼠肝移植RNA干扰模型,动物分为A组(冷保存2h肝移植组)、B组(供肝导入Bcl-2 SiRNA 24h冷保存2h移植组)、C组(二氮嗪预处理冷保存2h肝移植组)、D组(供肝导入Bcl-2 SiRNA 24h二氮嗪预处理冷保存2h肝移植组)和E组(供肝导入non-sence SiRNA24h冷保存2h移植组)。每组小鼠6只,移植术后24h采集标本,检测肝移植术后肝细胞病理形态学改变、血清中谷丙转氨酶(ALT)、谷草转氨酶(AST)浓度,肝组织Bcl-2 mRNA和蛋白表达及肝细胞凋亡率变化。
结果:
1.在小鼠肝细胞缺氧-复氧损伤模型中,A、B组细胞培养液中ALT、AST浓度与C组比较明显升高(P<0.01) ,A、B两组之间比较,细胞培养液中ALT、AST浓度在缺氧-复氧6h差异无统计学意义(P>0.05),12h、24h、48h和72h B组ALT、AST浓度明显低于A组(P<0.01)。A、B组肝细胞凋亡率均高于C组( P < 0.01),A、B两组之间比较,肝细胞凋亡率在缺氧-复氧6h差异无统计学意义(P>0.05),12h、24h、48h和72h B组肝细胞凋亡率明显低于A组(P<0.01)。肝细胞Bcl-2mRNA和蛋白表达,A组和C组中均较低,两组之间比较差异无统计学意义(P>0.05),B组中Bcl-2mRNA和蛋白表达明显高于A、C组,缺氧-复氧损伤6h、12h、24h、48h和72h B组与A组比较差异存在统计学意义( P <0.01)。
2.在小鼠肝移植模型中,A组术后生存率明显高于B组和C组。在小鼠肝移植RNA干扰模型中,D组Bcl-2mRNA表达量在6h开始明显下降,24h达到高峰,持续到72h,6h、24h、48h和72h Bcl-2mRNA表达较正常对照组分别减少36.0%、66.2%、61.8%、58.1%。E组小鼠肝脏组织中Bcl-2mRNA表达较G组减少33.3%,F组较G组减少58.9%,F组与E组两组之间比较,F组肝脏组织中Bcl-2mRNA表达较E组减少38.1% ,两组之间差异有统计学意义(P<0.05)。
3.在二氮嗪预处理小鼠肝移植实验中,C组Bcl-2 mRNA和蛋白表达水平较A组明显增高(P<0.01),Bcl-2mRNA和蛋白表达分别增加2.6倍和5.1倍;B组Bcl-2 mRNA和蛋白表达水平较A组明显降低(P<0.01),Bcl-2mRNA和蛋白表达分别被抑制57.1%和83.4%;D组Bcl-2 mRNA和蛋白表达水平较A组明显降低(P<0.01),Bcl-2mRNA和蛋白表达分别减少53.3%和67.6%;B组与D组两组之间比较Bcl-2 mRNA和蛋白表达水平差异无统计学意义(P>0.05)。C组中肝细胞病理损伤程度、凋亡指数、血清AST、ALT含量明显低于各组。B组和D组中肝细胞病理损伤程度、凋亡指数、血清AST、ALT含量明显高于各组。在各组中Bcl-2表达量与缺血再灌注损伤程度和肝细胞凋亡指数呈负相关。
结论:
1.二氮嗪预处理能通过抑制肝细胞凋亡,起到保护肝细胞缺氧-复氧损伤的作用,其保护机制可能与上调Bcl-2表达有关。
2.采用门静脉高压注射途径向肝脏导入Bcl-2 siRNA 24h后摘取供肝的方法建立肝移植模型,能在小鼠肝移植体内实现Bcl-2基因的有效沉默。
3.二氮嗪预处理可能通过诱导Bcl-2表达,抑制肝细胞凋亡,从而减轻小鼠肝移植缺血-再灌注损伤。
Objectives:
1. To investigate the impact of diazoxide preconditioning on the expression of Bcl-2 in liver cell and apoptosis during hypoxia-reoxygenation injury.
2. To silence the expression of Bcl-2 gene by delivery of synthetic Bcl-2 siRNA in mice orthotopic liver transplantation model.
3. To explore the effect of diazoxide preconditioning on attenuation ischemia- reperfusion injury in mice liver graft and to study the possible mechanism relating to apoptosis .
Methods:
1. The cultured hepatocytes were randomly divided into three groups with 6 cases each : groupA (anoxia -reoxygenation group) , groupB (diazoxide preconditioning group) and groupC (control group) . Samples were collected at 6h、12 h、24 h、48h and 72h after anoxia -reoxygenation . ALT、AST levels in nutritive medium were detected. Cell apoptosis were observed by TUNEL. The expressions of Bcl-2 gene and protein level were determined by RT-PCR and Western blot.
2. Orthotopic liver transplantations in mice were performed , mice were randomly divided into three groups namely:group A (cold preservation of 4h), group B (cold preservation of 8h)and group C (cold preservation of 12h) ,the survival ratio of each group was analysised 14days after operation. The Bcl-2 gene was silenced in liver graft mice by RNAi.Synthetic Bcl-2 siRNA sequence was delivered in vivo by using a‘‘hydrodynamic’’transfection method.siRNA sequence was delivered into the portal vein with a 29-G needle. Mice were randomly divided into four groups namely: group D (donor group), group E (liver transplantation group after Bcl-2 siRNA sequence was delivered in donor 6h), group F (liver transplantation group after Bcl-2 siRNA sequence was delivered in donor 24h) and group G (control group). Samples in group D (donor group) were collected at 6h、24h、48h and 72h after Bcl-2 siRNA sequence was delivered. Samples in groupE、F、G were collected after liver transplantation 24h . The expression of Bcl-2 gene level was determined by RT-PCR.
3. Orthotopic liver transplantations in mice were performed after Bcl-2 siRNA sequence was delivered in donor 24h, mice were randomly divided into five groups namely: groupA(the liver transplantation group),group B(Bcl-2 SiRNA sequence delivery liver transplantation group),group C(diazoxide preconditioning liver transplantation group), groupD(diazoxide preconditioning and Bcl-2 SiRNA sequence delivery liver transplantation group )and groupE(non-sense SiRNA sequence delivery liver transplantation group ).24h after liver transplantation, The pathological changes of liver tissue and the serum AST、ALT level were observed in each group .Cell apoptosis were observed by TUNEL.The expression of Bcl-2 gene and protein level were determined by RT-PCR and Western blot.
Results:
1.In the cultured hepatocytes ,the cell apoptosis index and the levels of AST、ALT in nutritive medium in group A、B were significantly higher than in group C (p<0.01), the cell apoptosis index and the levels of AST、ALT in nutritive medium in group B were significantly lower than in group A (p<0.01); The expression of Bcl-2 gene and protein level in group B were significantly higher than group A、C (p<0.01).
2. In the Orthotopic liver transplantation groups,the survival ratio of group A was higher than in group B、C after liver transplantation 14d(p<0.01).In the RNAi groups , the expression of Bcl-2 mRNA in group D was decreased gradually at 6h after siRNA sequence delivery, arrived on the top at 24h and continued to decrease at 72h . The expression of Bcl-2 mRNA in group D was inhibited 36.0%、66.2%、61.8%、58.1%respectively ,at 6h、24 h、48h and 72h after Bcl-2 siRNA sequence delivery. The expression of Bcl-2 mRNA in group E and F was decreased 33.3% and 58.9%, respectively ,compared with group G. The expression of Bcl-2 mRNA existed significant difference between group E and group F, The expression of Bcl-2 mRNA in group F was decreased 38.1% compared with group E.
3.In the diazoxide preconditioning liver graft groups, the levels of Bcl-2 mRNA and protein in group C were remarkably higher than group A (p<0.01). The expression of Bcl-2 in group C was improved by 2.6-fold and 5.1-fold, compared with group A, respectively at mRNA and protein levels. The levels of Bcl-2 mRNA and protein in group B were remarkably lower than group A (p<0.01),the expression of mRNA and protein were inhibited 65.7% and 83.4%,respectively. The levels of Bcl-2 mRNA and protein in group D were remarkably lower than group A (p<0.01),the expression of mRNA and protein were decreased 53.3% and 67.6%,respectively. There was no statistical difference of Bcl-2 mRNA and protein levels between group B and group D (p>0.05). The pathological injure degree of liver tissue、apoptosis index and the serum AST、ALT levels in group C were significantly lower than other groups; The pathological injure degree of liver tissue、apoptosis index and the serum AST、ALT levels in group B、D were significantly higher than other groups; There found negative correlation between expression of Bcl-2 and the degree of ischemia- reperfusion injury as well as hepatocyte apoptosis index in each group.
Conclusions:
1. Diazoxide preconditioning can attenuate the apoptosis of hepatocytes induced by anoxia -reoxygenation ,and the protective effect may be related to the expression of Bcl-2.
2. The method of liver transplantation was operated 24h after siRNA sequence was delivered into the portal vein of donor can realize Bcl-2 gene silencing in vivo of liver graft mice.
3. Diazoxide preconditioning can protect against ischemia-reperfusion injury in liver graft mice,with its possible mechanism of upregulating the expression of Bcl-2 and prohibiting hepatocyte apoptosis.
引文
1. Strasberg SM,Howard TK,Molmenti EP,et al.Selecting the doner liver:risk factors for poor function after orthotopic liver transplantation .Hepatology ,1994,20:829-836
2. Selzner N, Rudiger H, Graf R, Clavien PA. Protective strategies against ischemic injury of the liver. Gastroenterology 2003;125:917-936.
3. Ito K, Ozasa H , Nagashima Y, et al . Pharmacological preconditioning with doxorubicin. Implications of heme oxygenase-1 induction in doxorubicin induced hepatic injury in rats [ J ] . Biochem Pharmacol ,2001 ,62 (9) :1249 - 1255
4. Kume M ,Yamamoto Y,Yamagami K,et al. Pharmacological hepatic preconditioning : involvement of 70-kDa heat shock proteins (HSP72 and HSP73) in ischaemic tolerance after intravenous administration of doxorubicin[J ] .Br J Surg , 2000 , 87 (9) :1168 -1175
5. Nilsson B , Friman S ,Wallin M ,et al . The liver protective effect of ischemic preconditioning may be mediated by adenosine [ J ] .Transpl Int ,2000 , 13 Suppl 1 :558 - 561
6. Ardehali H ,O’Rourke B. Mitochondrial KATP channels in cell survival and death[J ] . J Mol Cell Cardiol ,2005 ;39 :7 - 16
7. Jaeschke H. Molecular mechanisms of hepatic ischemiareperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 2003;284:G15-26.
8. Hai S,Takemara S,Minamiyama Y,et al.Mitochondrial Katp channel opener prevents ischemia-reperfusion injury in rat liver [ J ] .Transplant Proc ,2005,37:428-431
9. Sasaki H , Matsuno T , Tanaka N , et al . Activation of apoptosis during the reperfusion phase after rat liver ischemia [J ] . Transplan Proc , 1996 ; 28 (3)∶1908-1916
10. Kuo PC , Drachenberg CI , de la Torre A , et al . Apoptosis and hepatic allograft reperfusion injury [J ] . Clin Transplant , 1998 ; 12 (3)∶219-227
11. Jae-Sung,Lihua He,John J Lemasters.Mitochondrial permeability transition:a common pathway to necrosis and apoptosis [J ].Biochemical and Biophysical Research Communications.2003,304(3):463-470
12. Liu D, Lu C, Wan R et al,Activation of mitochondrial ATP-dependent potassiumchannels protects neurons against ischemia-induced death by a mechanisms involving suppression of Bax translocation and cytochrome c release, J. Cereb. Blood FlowMetab. 2002, 22 (4) : 431-433.
13. Fabio Di Lisa,Marcella Canton ,Roberta Menabo ,et al .Mitochondia and reperfusion injury–the role of permeability transition [J ].Basic Res Cardiol,2003,98(4):235-241
14. Kienle K, RentschM, Müller T, et al. Expression of Bcl-2 in liver grafts after adenoviral transfer improves survival following prolonged ischemia and reperfusion in rat liver transplantation [ J ]. Transp lant Proc,2005, 37: 439 - 441
1. Jaeschke H. Molecular mechanisms of hepatic ischemiareperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 2003;284:G15-26.
2. Tsujimoto, Y. Cell death regulation by the Bcl-2 protein family in the mitochondria. J.Cell. Physiol. 2003,195:158-167.
3. Carini R , Grazia M ,Splendore R ,et al. Sigal pathway invoved in the development of hypoxic preconditioning in rat hepatocytes. Hepatology ,2001 ,33 :131-139.
4.汪炜健刘荣国史春霞,等.二氮嗪预处理对缺氧复氧后大鼠海马神经元凋亡的影响.中华麻醉学杂志.2006,26(3):252-254
5. Tsouka V , Markou T , Lazou A. Differential effect of ischemic and pharmacological preconditioning on PKC isoform translocation in adult rat cardiac myocytes[J ] . Cell Physiol Biochem , 2002 ,12(5-6): 315-325
6. Carini R , De Cesaris MG, Splendore R ,et al . Ischemic precondition ingreduces Na ( + ) accumulation and cell killing in isolated rat hepatocytes exposed to hypoxia. Hepatology , 2000 , 31 : 166-172.
7. Carini R , Grazia M ,Splendore R ,et al. Sigal pathway invoved in the developement of hypoxic preconditioning in rat hepatocytes. Hepatology ,2001 ,33 :131-139.
8.杨红张文健吴练秋,等.ɑ-1抗胰蛋白酶对肝窦内皮细胞缺氧-复氧损伤保护作用的实验研究.中华医学杂志.2005,85(2):106-110
9. Iu S, Harvey PRC, Makowka L, Petrunka CN, Ilson RG,Strasberg SM. Markers of allograft viability in the rat.Relatinship between transplantation viability and liver function in the isolated perfused rat liver. Transplantation 1987;45:562-569.
10. Ardehali H ,O’Rourke B. Mitochondrial KATP channels in cell survival and death[J ] . J Mol Cell Cardiol ,2005 ;39 :7–16
11. Imahashi K,Nishimura T, Yoshioka J , et al. Role of intracellular Na + kinetics in p reconditioned rat heart[ J ]. Circ Res, 2001, 88 (11) : 1176-1182.
12. SamavatiL,MonickMM, Sanlioglu S, et al. Mitochondrial KATP channel openers activate the ERK kinase by an oxidant-dependent mechanism [ J ]. Am J Physiol Cell Physiol, 2002, 283 (1) : C273-C281.
13. McCully JD,Wakiyama H, Cowan DB, et al. Diazoxide amelioration of myocardial injury and mitochondrial damage during cardiac surgery [ J ]. Ann Thorac Surg, 2002, 74 (6) : 2138-2145.
14. Garlid K D,Paucek P,Yarov-Yarovoy V,et al.The mitochondrial KATP channel openers[J ].J Biol Chem.1996,271(15):8796-8799
15. Bolli R. The late p hase of preconditioning[J ] . Circ Res ,20 00 ,87 (11) :973-983
16. Jaeschke H. Molecular mechanisms of hepatic ischemia reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 2003;284:G15-26.
17. Sasaki H , Matsuno T , Tanaka N , et al . Activation of apoptosis during the reperfusion phase after rat liver ischemia [J ] . Transplan Proc , 1996 ; 28 (3)∶1908-1919
18. Kuo PC , Drachenberg CI , de la Torre A , et al . Apoptosis and hepatic allograft reperfusion injury [J ] . Clin Transplant , 1998 ; 12 (3)∶219-231
19. Jae-Sung,Lihua He,John J Lemasters.Mitochondrial permeability transition:a common pathway to necrosis and apoptosis [J ].Biochemical and Biophysical Research Communications.2003,304(3):463-470
20. Liu D, Lu C, Wan R et al,Activation of mitochondrial ATP-dependent potassium channels protects neurons against ischemia-induced death by a mechanisms involving suppression of Bax translocation and cytochrome c release, J. Cereb. Blood FlowMetab. 2002, 22 (4) : 431-433.
21. Fabio Di Lisa,Marcella Canton ,Roberta Menabo ,et al .Mitochondia and reperfusion injury–the role of permeability transition [J ].Basic Res Cardiol,2003,98(4):235-241
1. Selzner N, Rudiger H, Graf R, Clavien PA. Protective strategies against ischemic injury of the liver. Gastroenterology 2003;125:917-36.
2. Hendreson JM.Liver transplantation and rejection:an overview.Hepato–Gastroenterol 1999;46:1482-1484.
3. Pagliaro P, Gattullo D, Rastaldo R, et al. Ischemic p reconditioning: from the first to the second window of protection[ J ]. Life Sci , 2001, 69 (1) :1 - 15.
4. Tsujimoto, Y. Cell death regulation by the Bcl-2 protein family in the mitochondria. J.Cell. Physiol. 2003,195, 158-167 .
5. Kamada N, Calne RY. Surgical experience with five hundred thirty liver transplants in the rat[ J ]. Surgery, 1983, 93 (1 Pt 1) : 64 - 69.
6. Lewis DL, Hagstrom JE, Loomis AG, Wolf Ja, Herweijer H.Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nature Genet 2002;32:107-108.
7. Qian SG,Fung JJ,Demetris AJ,et al .Orthotopic liver transplantation in the mouse . Transplantation,1991,52:562-564
8. Ploeg RJ, D’Alessandro AM,Knechtle SJ,et al. Risk factors for primarydysfunction after liver transplantation--amultivariate analysis.Transplantation.1993;55(4): 807- 813.
9. Tian Y,Rudiger HA,Juchum W,et al .Comparison of arterialized and non arterialized orthotopic liver transplantation in mice . Transplantation,2002,74:1242-1246
10. Steger U,Sawjtzkj B,Gassel AM,et al.Impact of hepatic rearterialization on reperfusion injury and outcome after liver transplantation. Transplantation, 2003,76: 327-332
11.陈志宇,张玉君,王曙光等.小鼠原位肝移植模型的建立.中华实验外科杂志。2006,23(10):1261-1262
12. Hammond SM, Boettcher S, Caudy A A, et al. Argonaute , a link between genetic and biochemical analyses of RNAi [ J ]. Science, 2001, 293 (5532) : 1146-1150.
13. ZenderL, Hutker S, Liedtke C, et al. Caspase 8 small interfering RNA prevents acute liver failure in mice [ J ]. Proc Natl Acad SciUSA, 2003, 100 (13) : 7797-7802.
14. Layzer J M, McCaffreyA P, TannerA K, et al. In vivo activity of Nuclease resistantsiRNAs[ J ]. RNA, 2004, 10 (5) : 766-771.
15. Rusckowski, M., Ou, T., Roskey, A., and Agrawal, S. Biodistribution and metabolism of a mixed backbone oligonucleotide (GEM 231) following single and multiple dose adminstration in mice. Antisense Nucleic Acid Drug Dev. 2000. 10:333-345.
1. Selzner N, Rudiger H, Graf R, Clavien PA. Protective strategies against ischemic injury of the liver. Gastroenterology 2003;125:917-936.
2. Jaeschke H. Molecular mechanisms of hepatic ischemiareperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 2003;284:G15-26.
3. Fabio Di Lisa,Marcella Canton ,Roberta Menabo ,et al .Mitochondia and reperfusion injury–the role of permeability transition [J ].Basic Res Cardiol,2003,98(4):235-241.
4. Shigeomi Shimizu,Toku Kanaseki, Noboru Mizushima. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes Nature Cell Biology 2004:6:1221-1234
5. Ockaili R ,Emani VR ,Okubo S ,et al . Opening of mitochondrial KATPchannel induces early and delayed cardioprotective effect : role of nitricoxide[J ] . Am J Physiol Heart Circ Physiol , 1999 , 277 (6) : 2425 -2434.
6. Eckhoff DE, Bilbao G, Frenette L, Thompson JA, Contreras JL. 17-Beta-estradio protects the liver against warm ischemia/reperfusion injury and is associated with increased serum nitric oxide and decreased tumor necrosis factor-alpha. Surgery 2002;132:302-309
7. Beilharz E, Williams C, Dragunow M, Sirimanne E, Gluckman P. Mechanisms of delayed cell death following hypoxic-ischemic injury in the immature rat: evidence for apoptosis during selective neuronal loss. Brain Res Mol Brain Res 1995; 29: 1-6
8. Motoyama S, Minamiya Y, Saito S, et al. Hydrogen peroxide derived from hepatocytes induces endothelial cell apoptosis in perfused hypoxic rat liver. Gastroenterology 1998; 114: 153-164
9. Kohli, Vivek, Selzner,Markus,Madden, et al. Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion after ischemia-reperfusion injury in the rat liver. Transplantation. 1999, 67(8)27:1099-1105
10. Strasberg SM,Howard TK,Molmenti EP,et al.Selecting the doner liver:risk factors for poor function after orthotopic liver transplantation .Hepatology ,1994,20:829-837
11. Ito K, Ozasa H , Nagashima Y, et al . Pharmacological preconditioning with doxorubicin. Implications of heme oxygenase-1 induction in doxorubicin inducedhepatic injury in rats [ J ] . Biochem Pharmacol ,2001 ,62 (9) :1249-1255
12. Kume M ,Yamamoto Y,Yamagami K,et al. Pharmacological hepatic preconditioning : involvement of 70-kDa heat shock proteins (HSP72 and HSP73) in ischaemic tolerance after intravenous administration of doxorubicin[J ] .Br J Surg , 2000, 87 (9) :1168 -1175
13. Nilsson B , Friman S ,Wallin M ,et al . The liver protective effect of ischemic preconditioning may be mediated by adenosine [ J ] .Transpl Int ,2000 , 13 Suppl 1 :558 - 561
14. Harmeet Malhi ,Gorla , Irani , et al . Cell transplantation after oxidative hepatic preconditioning with radiation and ischemia-reperfusion leads to extensive liver repopulation [ J ] . Proc Natl Acad Sci USA ,2002 , 99 (20) : 13114 - 13119
15. Terajima H ,Enders G , Thiaener A , et al. Impact of hyperthermic preconditioning on postischemic hepatic microcirculatory disturbances in an isolated perfusion model of the rat liver [J ] . Hepatolgy ,2000 , 31 (2) :407-415
16. Marc ARC Daemen ,Heemskerk , Veer , et al. Functional protection by acute phase proteinsɑ1-acid glycoprotein and inflammation[J ] . Circulation ,2000 , 102 (12) : 1420
17. Ardehali H ,O’Rourke B. Mitochondrial KATP channels in cell survival and death[J ] . J Mol Cell Cardiol ,2005 ;39 :7-16
18. Hai S,Takemara S,Minamiyama Y,et al.Mitochondrial Katp channel opener prevents ischemia-reperfusion injury in rat liver [ J ] .Transplant Proc ,2005,37:428-431
19. Kohli V ,Selzner M,Maden JF , et al . Endothellal cell and hepatocyte death occur by apoptosis after ischemia-reperfusion injury in the rat liver[J] . Transplantation ,1999 ,67 (8) :1099-1105.
20. Sasaki H ,Matsuno T ,Tanaka N , et al . Induction of apoptosis during the early phase of reperfusion after rat liver ischemia[J ] . Acta Med Okayama ,1997 ,51(6) :305-312
21. Kuo PC ,Drachenberg CI ,de la Torre A , et al . Apoptosis and hepatic allograft reperfusion injury[J ] . Clin Transplant ,1998 ,12(3) :219-225
22. Kienle K, RentschM, Müller T, et al. Expression of Bcl-2 in liver grafts after adenoviral transfer improves survival following prolonged ischemia and reperfusion in rat liver transplantation [ J ]. Transp lant Proc,2005, 37: 439-441
23. Oltval Z ,Milliman C ,Korsmeyer S.Bcl-2 heterodimerizes in vivo with a conserved homolog, bax , that accelerates programmed cell death [ J ] .Cell ,1993 ,74(4) :609-619.
1. Morioka O , Kubota T , Sekido H , et al . Prostaglandin E1 improved the function of transplanted fatty liver in a rat reduced-size-liver transplantation model under conditions of permissible cold preservation[J ] .Liver Transpl , 2003 ,9 (1) :79-86.
2. Shah V , Kamath PS. Nitric oxide in liver transplantation : Pathobiology and clinical implications[J ] . Liver Transpl ,2003 ,9(1) :1-11.
3. Liu W,Schob O,Pugmire JE,et al.Glycohydrolases as markers of hepatic ischemia- reperfusion injury and recovery.Hepatology,1996,24(1):157-162.
4. Mizunuma K, Ohdan H , Tashiro H , et al . ROCK inhibitor Y-27632 prevents primary graft non-function caused by warm ischemia- reperfusion in rat liver transplantation[J ] . Transpl Int , 2002 ,15 (12) :623-629.
5. Khandoga A , Biberthaler P , Enders G, et al . P2selectin mediates platelet-endothelial cell interactions and reperfusion injury in the mouse liver in vivo[J ] . Shock ,2002 ,18 (6) :529-535.
6. DingWX, Yin XM. Dissection of themultiple mechanisms of TNF - alpha - induced apoptosis in liver injury [ J ]. J Cell Mol Med,2004, 8: 445 - 454.
7. NeumanMG. Apoptosis in diseases of the liver [ J ]. Crit Rev Clin Lab Sci, 2001, 38: 109-166.
8. XuWH, Ye QF, Xia SS. Apop tosis and p roliferation of intrahepatic bile duct after ischemia- reperfusion injury [ J ]. Hepatobiliary Pancreat Dis In, 2004, 3: 428 - 432.
9. J iang H, Meng F, Li J, et al. Anti - apoptosis effects of oxymatrine protect the liver from warm ischemia reperfusion injury in rats [ J ].World J Surg, 2005, 29: 1397 - 1401.
10. Alessenko AV, Galperin EI, Dudnik LB, et al.Role of tumor necrosis factor alpha and sphingomyelin cycle activation in the induction of apop tosis by ischemia / reperfusion of the liver[ J ]. Biochemistry, 2002, 67: 1347 - 1355.
11. Skulachev VP, Longo VD. Aging as a mitochondria - mediated atavistic p rogram: can aging be switched off [ J ] Ann N Y Acad Sci,2005, 1057: 145 - 164.
12. Chang EJ, Lee SH, Mun KC, et al. Effect of artificial cells on hepatic function afterischemia - reperfusion injury in liver [ J ]. Transplant Proc, 2004, 36: 1959 - 1961.
13. Peralta C, Xaus C, Bartrons R, et al. Effect of ozone treatment on reactive oxygen species and adenosine production during hepatic ischemia - reperfusion [ J ]. Free Radic Res,2000, 33: 595 - 605
14. Nakagawa T, Shimizu S, Watanabe T, et al.Cyclophilin D - dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death [ J ]. Nature, 2005,434: 652 - 658.
15. Kim JS, Qian T, Lemasters JJ. Mitochondrial permeability transition in the switch from necrotic to apoptotic cell death in ischemic rat hepatocytes [ J ]. Gastroenterology, 2003,124: 494 - 503.
16. Vilatoba M, Eckstein C, Bilbao G, et al.Sodium 4 - phenylbutyrate p rotects against liver ischemia reperfusion injury by inhibition of endoplasmic reticulum - stress mediated apoptosis [ J ]. Surgery, 2005, 138: 342- 351.
17. Kitano H, Nishimura H, Tachibana H, et al.ORP150 ameliorates ischemia / reperfusion injury from middle cerebral artery occlusion in mouse brain[ J ]. Brain Res, 2004, 1015: 122- 128.
18. ShibataM, Hattori H, Sasaki T, et al. Activation of caspase - 12 by endoplasmic reticulum stress induced by transient middle cerebral artery occlusion in mice [ J ]. Neuroscien, 2003, 118: 491 - 499.
19. MiyagawaY,Imamura H,Soeda J,et al .Fate of hepatocytes and sinusoidal lining cell function and kinetics after extended cold preservation and transplantation of rat liver .Liver Transpl,2002,8:370-381
20. Shinoda M, Shimazu M, Wakabayashi G, et al . Tumor necrosis factor suppression and microcirculatory disturbance amelioration in ischemia-reperfusion injury of rat liver after ischemic preconditioning [ J ] . JGastroenterol Hepatol , 2002 ,17 (11):1211-1219.
21. Harada H ,Wakabayashi G,Takayanagi A , et al . Transfer of the interleukin1 receptor antagonist gene into rat liver abrogates hepatic ischemia/reperfusion injury [ J ] . Transplantation , 2002 , 74 ( 10) : 1434-1441.
22.孙备,姜洪池细胞凋亡与缺血-再灌注损伤的研究进展[J ] .国外医学外科学分册,1998 ,25(6) :325-326.
23.孙备,姜洪池.肝移植供肝保护的研究进展[J ]国外医学外科学册,2000,27(3) :135-138.
24. Nilsson B, F riman S, Gustafsson B I, et al. Preconditioning protects against ischem ia/reperfusion injury of the liver [J ]. J Gastrointest Su rg. 2000,4 (1) : 44-49.
25. Sawaya DE J r, BrownM , M inardiA , et al. The role of ischemic preconditioning in the recruitment of rolling and adherent leukocytes in hepatic venules after ischemia/ reperfusion [ J ]. JS u rg R es. 1999 ; 85 (1) : 163-170.
26. Yin DP, Sankary HN , Chong A S, et al. P rotective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats[J ]. T ransplantation. 1998 ,27; 66 (2):152-157.
27. Schulz R, Gres P, Heusch G. Role of endogenous opioids in ischemic preconditioning but not in short-term hibernation in pigs[J ]. A m J P hy siol Heart Circ Physiol. 2001, 280 (5): 2175-2181.
28. Clavien PA , Yadav S, Sindram D, et al. P rotective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans [J ]. Ann Surg. 2000 , 232 (2) :155-162.
29. Clavien PA , Selzner M , Rudiger HA , et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic p reconditioning[J ],Ann Surg , 2003, 238: 843-852.
30. Chouker A , Schachtner T, Schauer R, et al. Effects of Pringlet manoeuvre and ischaem ic preconditioning on haemodynamic stability in patients undergoing elective hepatectomy: a randomized trial[J ]. Br J A naesth. 2004,93 (2) :204-211.
31. Li SQ , Liang LJ , Huang JF, et al. Ischemic preconditioning protects liver from hepatectomy under hepatic inflow occlusion for hepatocellular carcinoma patients with cirrhosis[J ]. W orld J Gastroenterol. 2004 , 10 (17) : 2580-2584.
32. Nuzzo G, Giuliante F, Vellone M , et al. Pedicle clamping with ischemic preconditioning in liver resection [ J ]. L iver T ranspl.2004 , 10 (2) : S53-57.
33. Singh AK,Mani H ,Seth P , et al . Picroliv preconditioning protects the rat live against ischemia-reperfusion injury[J ] . Eur J Pharmacol ,2000 ,395 (3) :229-239.
34. Wieland E ,Schutz E ,Armstrong VW, et al . Idebenone protects hepatic microsomes against oxygen radical-mediated damage in organ preservation solution[J ] . Transplantation ,1995 ,60(3) :444-451.
35. Klein M,Geoghegan J ,Wangemann R , et al . Preconditioning of donor livers with prostaglandin I2 before retrieval decreases hepatocellular ischemia-reperfusion injury [ J ] . Transplantation , 1999 , 67 ( 8) :1128-1132.
36. Merion RM. Prostaglandins in liver transplantation [ J ] . Adv ExpMed Biol, 1997, 433(1) :132-18.
37. Peralta C , Bulbena O ,Bargallo R , et al . Strategies to modulate the deleterious effects of endothelin in hepatic ischemia-reperfusion [J ] .Transplantation, 2000, 70(12): 1761- 1770.
38. Howell JG, Zibari GB ,Brown MF , et al . Both ischemic and pharmacological preconditioning decrease hepatic leukocytePendothelial cellinteractions [J ] . Transplantation, 2000 ,69 (2) :300-303.
39. Lee MH , Bae SK,Kim YG, et al . Dose-independent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage ,KR-31543 , after intravenous and oral administration to rats : Hepatic and intestinal first-pass effects[J ] . J Pharm Sci , 2003 ,92 (1) :190-201.
40. Glanemann M, Vollmar B , Nussler AK, et al . Ischemic preconditioning protects from hepatic ischemia- reperfusion injury by preservation of microcirculation and mitochondrial redox-state[J ] . J Hepatol ,2003 ,38 (1) :59-66.
41. Zhu XH ,Qiu YD ,Shen H ,et al. Effect of matrine on Kupffer cell activation in cold ischemia reperfusion injury of rat liver[J ] . World J Gastroenterol ,2002 ,8 :1112-1223
42. Schauer RJ ,Bilzer M ,Kalmuk S ,et al. Microcirculatory failure after rat liver transplantation is related to Kupffer cell derived oxidant stress but not involved in early graft dysfunction[J ] . Transplantation ,2001 ,72 :1692-1702
43. Charrueau CA , Carayon A , Thurman RG. Long-term cold liver storage induces endothelin-1 release and a time-dependent increase in portal pressure at reperfusion in the rat [J ] .J Gastroenterol ,2002 ,37 :717-721
44. Kume M ,Yamamoto Y,Yamagami K,et al. Pharmacological hepatic preconditioning : involvement of 702kDa heat shock proteins(HSP72 and HSP73) in ischemic tolerance after intravenous administration of doxorubicin [ J ] . Bri J Surg ,2000 ,87 :1168-1183
45. Fudaba Y, Ohsan H , Tashiro H , et al. Geranylger anylacetone ,a heat shock protein inducer ,prevents primary graft nonfunction in rat liver transplantation [ J ] .Transplantation ,2001 ,72 :184-193
46.苏东,李昆.抑肽酶预处理防护大鼠肝脏缺血再灌注损伤的实验研究[J ] .重庆医学, 2002 ,31 (8) :709-713
47.陈莉芬,胡长林.复方阿魏酸对实验性脑缺血再灌注损伤热休克蛋白70的作用[J ] .重庆医学,2002 ,31 (11) :1061-1067
48. Coito AJ ,Buelow R ,Shen XD ,et al. Heme oxygenase-1 gene transfer inhibits inducible nitric oxide synthase expression and protects genetically fat Zuker rat livers from ischemia-reperfusion injury[J ] . Transplantation ,2002 ,74 :96-105
49. Harada H ,Wakabayashi G, Takayanagi A ,et al. Transfer of the interleukin-1 receptor antagonist gene into rat liver abrogates hepatic ischemia-reperfusion injury [ J ] . Transplantation, 2002 ,74 :1434-1443
50. Ichihara T ,Komagata Y, Yang XL ,et al. Resistance to fulminant hepatitis and carcinogenesis conferred by overpression of retinoblastoma protein in mouse liver [ J ] . Hepatology ,2001 ,33 :948-957
51. Lehmann TG,Wheeler MD ,Schoonhoven R ,et al. Delivery of Cu/ Zn-superoxide dismutase genes with a viral vector minimizes liver injury and improves survival after liver trans plantation in the rat [J ] . Transplantation ,2000 ,69 :1051-1059
52. Levy MF ,Crippin J ,Sutton S ,et al. Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/hCD59) porcine livers[J ] . Transplantation, 2000, 69 :272-280
1. Bernstein E, CaudyA A, Hammond SM, et al. Role for a bidentate ribonuclease in the initiation step of RNA interference [ J ].Nature, 2001, 409 (6818) : 363-366.
2. Hammond SM, Bernstein E, Beach D, et al. An RNA-directed nuclease mediates post transcrip tional gene silencing in Drosophila cells[ J ]. Nature, 2000, 404 (6775) : 293-296.
3. Nykanen A, Haley B, Zamore P D. ATP requirements and small interfering RNA structure in the RNA interference pathway [ J ].Cell, 2001, 107 (3) : 309-321.
4. Fire A , Xu S , Montgomery MK, et al . Potent and specific genetic interference by dsRNA in caenorhabditis elegans [J ] . Nature ,1998 ,391 :806 - 811.
5. Caplen NJ , Fleenor J , Fire A , et al . DsRNA - mediated gene silencing in cultured Drosophila cells[J ] . Gene ,2000 ,252 :95 - 105.
6. Svoboda P ,Stein P , Hayashi H , et al . Selective reduction of dormant maternal mRNAs in mouse oocytes by RNA interference[J ] . Development ,2000 ,127 :4147 - 4156.
7. Zamore PD ,Tuschl T ,Sharp PA , et al . RNAi :dsRNA directs the ATP- dependent cleavage of mRNA at 21 to 23 nucleotide intervals [ J ] .Cell ,1999 ,101 :25 - 33.
8. Hommond SM . An RNA - directed nuclease mediates PTGS in Drosophila cells[J ] . Nature ,2000 ,404 :293 - 296.
9. Elbashir SM, Harbort H, Lendackel , et al . Duplexes of 21– nucleotide RNAs medate RNA interference in cultured mammalian cells [J ] . Nature ,2000 ,411 :494 - 498.
10. Hammond SM, Boettcher S, Caudy A A, et al. Argonaute 2, a link between genetic and biochemical analyses of RNAi [ J ]. Science, 2001, 293 (5532) : 1146-1150.
11. Takasaki S, Kawamura Y, Konagaya A. Selecting effective siRNA sequences based on the self2organizing map and statistical techniques[ J ]. Comput Biol Chem, 2006, 30 (3):169-178.
12. Russell P, Walsh E, ChenW, et al. The effect of temperature on gene silencing by siRNAs: Imp lications for silencing in the anterior chamber of the eye[ J ]. Exp Eye Res, 2006, 82 (6) : 1011-1016.
13. Martin S E, Cap len N J. Mismatched siRNAs downregulate mRNAs as a function oftarget site location [ J ]. FEBS Lett, 2006,580 (15) : 3694-3698.
14. Fraser AG. Fuctional genomic analysis of cell division in C elegans chrosome 1 by systematic RNAi [J ] . Nature ,2000 ,408 :325 - 330
15. Gonczy P ,Echeverri G, Oegema K, et al . Functional genomic analysis of cell division in C. elegans using RNAi of genes on chromosome III [J ] . Nature ,2000 ,408 :331 - 336.
16. Zhang C, Tang C, Liu X, et al. SiRNA-containing liposomesmodified with polyarginine effectively silence the targeted gene [ J ]. J Control Release, 2006, 112 (2) : 229-239.
17. Marschall P, Malik N, Larin Z. Transfer of YACs up to 2. 3Mb intact into human cells with polyethylenimine [ J ]. Gene Ther,1999, 6 (9) : 1634-1637.
18. Goula D, Benoist C, Mantero S, et al. Polyethylenimine-based intravenous delivery of transgenes to mouse lung [ J ]. Gene Ther,1998, 5 (9) : 1291-1295.
19. GodbeyW T, BarryM A, Saggau P, et al. Polyethylenimine-mediated transfection: a new paradigm for gene delivery[ J ]. J Biomed Mater Res, 2000, 51 (3) : 321-328.
20. Brus C, Kleemann E, AignerA, et al. Stabilization of oligonucleotide polyethylenimine comp lexes by freeze drying: physicochemical and biological characterization [ J ]. J Control Release, 2004,95 (1) : 119-131.
21. Hornung V, Guenthner,BillerM, Bourquin C, et al. Sequence-specific potent induction of IFN-αby short interfering RNA in p lasmacytoid dendritic cells through TLR7 [ J ]. Nat Med, 2005, 11(3) : 263-270.
22. Judge A D, Sood V, Shaw J R, et al. Sequence-dependent stimulation of the mammalian innate immune resonse by synthetic siRNA[J]. Nat Biotechnol, 2005, 23 (4) : 457-462.
23. Werth S, Urban Klein B, Dai L, et al. A low molecular weight fraction of polyethylenimine ( PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes [ J ]. J Control Release, 2006, 112 (2) : 257-270.
24. ReadM L, Singh S, Ahmed Z, et al. A versatile reducible polycation-based system for efficient delivery of a broad range of nucleicacids[J]. Nucleic Acids Res, 2005, 33 (9) : e86.
25. Martin S E, Cap len N J. Mismatched siRNAs downregulate mRNAs as a function of target site location [ J ]. FEBS Lett, 2006,580 (15) : 3694-3698.
26. Yin C, Xi L, Wang X, et al. Silencing heat shock factor 1 by small interfering RNA abrogates heat shock-induced cardiop rotection against ischemia-reperfusion injury inmice [ J ]. J Mol CellCardiol, 2005, 39 (4) : 681-689.
27. Hassani Z, Lemkine G F, Erbacher P, et al. Lipid-mediated siRNA delivery down-regulates exogenous gene exp ression in the mouse brain at picomolar levels[ J ]. J Gene Med, 2005, 7 ( 2) :198-207.
28. PalliserD, ChowdhuryD, WangQ Y, et al. An siRNA-based microbicide protectsmice from lethal herpes simp lex virus infection [ J ]. Nature, 2006, 439 (7072) : 89-94.
29. Dubey P K, Mishra V, Jain S, et al. Liposomesmodified with cyclic RGD peptide for tumor targeting[ J ]. J Drug Target, 2004, 12 (5) : 257-264.
30. Soutschek J, Akinc A, Bramlage B, et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs[J]. Nature, 2004, 432 (7014) : 173-178.
31. ThomasM, Lu J J, Ge Q, et al. Full deacylation of poly ethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung[ J ]. Proc Natl Acad Sci USA, 2005, 102 ( 16 ):5679-5684.
32. Hwa Kim S, Hoon Jeong J, Chul Cho K, et al. Target-specific gene silencing by siRNA plasmid DNA comp lexed with folatemodified polyethylenimine [ J ]. J Control Release, 2005, 104 ( 1 ) :223-232.
33. Song E, Zhu P, Lee S K, et al. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface recep tors [ J ].Nat Biotechnol, 2005, 23 (6) : 709-717.
34. Simeoni F, MorrisM C, Heitz F, et al. Peptide-based strategy for siRNA delivery into mammalian cells [ J ]. Methods Mol Biol,2005, 309: 251-260.
35. de Jonge J, Holtrop M, Wilschut J, et al. Reconstituted influenza virus envelopes as an efficient carrier system for cellular delivery of smallinterfering RNAs[ J ]. Gene Ther, 2006, 13 (5) : 400-411.
36. Inoue A, Takahashi KA, Mazda O, et al. Electro-transfer of small interfering RNA ameliorated arthritis in rats[ J ]. Biochem Biophys Res Commun, 2005, 336 (3) : 903-908.
37. Kim TW, Lee J H, He L, et al. Modification of professional antigen presenting cellswith small interfering RNA in vivo to enhance cancer vaccine potency[ J ]. Cancer Res, 2005, 65 (1) : 309-316.
38. ZenderL, Hutker S, Liedtke C, et al. Caspase 8 small interfering RNA prevents acute liver failure in mice [ J ]. Proc Natl Acad SciUSA, 2003, 100 (13) : 7797-7802.
39. Layzer J M, McCaffreyA P, TannerA K, et al. In vivo activity of nuclease-resistant siRNAs[ J ]. RNA, 2004, 10 (5) : 766-771.
40. Giladi H, Ketzinel Gilad M, Rivkin L, et al. Small interfering RNA inhibits hepatitis B virus replication in mice [ J ]. Mol Ther,2003, 8 (5) : 769-776.
41. Sen A, Steele R, Ghosh A K, et al. Inhibition of hepatitis C virus protein expression by RNA interference[ J ]. Virus Res, 2003, 96(122) : 27-35.
42. DuxburyM S, Matros E, Ito H, et al. Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer[ J ].Ann Surg, 2004, 240 (4) : 667-674.
43. Fire A. RNA - triggered gene silencing[J ] . TIG,1999 ,15 :358 - 361.
44. Elbashir SM, Harbort H , Lendackel , et al . Duplexes of 21 - nucleotide RNAs medate RNA interference in cultured mammalian cells [J ] . Nature ,2000 ,411 :494 - 498.
1. Selzner N, Rudiger H, Graf R, Clavien PA. Protective strategies against ischemic injury of the liver. Gastroenterology 2003;125:917-36.
2. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 2003;284:G15-26.
3. Borghi-Scoazec G, Scoazec JY, Durand F, Bernuau J, Belghiti J, Feldman J, Henin D, et al. Apotpsis after ischemiareperfusion in human liver allografts. Liver Transpl Surg 1997;3:407-15.
4. Kohli V, Selzner M, Madden JF, Bentley RC, Clavien PA. Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. Transplantation 1999;67:1099-105.
5. Clavien PA, Harvey PR, Strasberg SM. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation 1992;53:957-78.
6. Lentsch AB, Kato A, Yoshidome H, McMasters KM, Edwards MJ. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology 2000;32:169-73.
7. Lindsten T,Zong W X,Thompson CB.Defining the role of the Bcl-2 family of proteins in the nervous system.Neuroscientist 2005,ll(1):10-15.
8. Kis B,Rajapakse NC,Snipes JA,Nagy K,Horiguchi T,Busija DW.Diazoxide induces delayed preconditioning in cultured rat cortical neurons.J Neurochem 2003: 87(4): 969-980.
9. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124– 36.
10. Cohen MV, Baines CP, Downey JM. Ischemic preconditioning: from adenosine receptor to KATP channel. Annu Rev Physiol 2000;62:79–109.
11. Lim, K.H., Javadov, S.A., The effect of ischemic preconditioning, diazoxide and 5- hydroxydecanoate on rat heart mitochondrial volume and respiration.Journal of Physiology.2002,545, 961–974.
12. Hai S,Takemara S,Minamiyama Y,et al.Mitochondrial Katp channel opener preventsischemia-reperfusion injury in rat liver [ J ] .Transplant Proc ,2005,37:428-431
13. Iu S, Harvey PRC, Makowka L, Petrunka CN, Ilson RG,Strasberg SM. Markers of allograft viability in the rat.Relatinship between transplantation viability and liver function in the isolated perfused rat liver. Transplantation 1987;45:562-9.
14. Kuo PC , Drachenberg CI , de la Torre A , et al . Apoptosis and hepatic allograft reperfusion injury [J ] . Clin Transplant , 1998 ; 12 (3)∶219
15. Eliseev RA,Vanwinkle B,Rosier RN,Gunter TE.Diazoxide-mediated preconditioning against apoptosis involves activation of cAMP-response element-binding protein(CREB)and NFkappaB.J Biol Chem 2004;279(45):46748-46754.
16. Hetz C,Viae PA,Bombrun A,Rostovtseva TK,M ontessuit S,Hiver A,Schwarz M K,Church DJ,Korsmeyer SJ,Martinou JC.An tonsson B.Bax channel inhibitors prevent mitochondrion-mediated apoptosis and protect neurons in a model of global brain ischemia.J Biol Chem 2005;280(52):42960-42970.
2. Selzner N, Rudiger H, Graf R, Clavien PA. Protective strategies against ischemic injury of the liver. Gastroenterology 2003;125:917-936.
3. Ito K, Ozasa H , Nagashima Y, et al . Pharmacological preconditioning with doxorubicin. Implications of heme oxygenase-1 induction in doxorubicin induced hepatic injury in rats [ J ] . Biochem Pharmacol ,2001 ,62 (9) :1249 - 1255
4. Kume M ,Yamamoto Y,Yamagami K,et al. Pharmacological hepatic preconditioning : involvement of 70-kDa heat shock proteins (HSP72 and HSP73) in ischaemic tolerance after intravenous administration of doxorubicin[J ] .Br J Surg , 2000 , 87 (9) :1168 -1175
5. Nilsson B , Friman S ,Wallin M ,et al . The liver protective effect of ischemic preconditioning may be mediated by adenosine [ J ] .Transpl Int ,2000 , 13 Suppl 1 :558 - 561
6. Ardehali H ,O’Rourke B. Mitochondrial KATP channels in cell survival and death[J ] . J Mol Cell Cardiol ,2005 ;39 :7 - 16
7. Jaeschke H. Molecular mechanisms of hepatic ischemiareperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 2003;284:G15-26.
8. Hai S,Takemara S,Minamiyama Y,et al.Mitochondrial Katp channel opener prevents ischemia-reperfusion injury in rat liver [ J ] .Transplant Proc ,2005,37:428-431
9. Sasaki H , Matsuno T , Tanaka N , et al . Activation of apoptosis during the reperfusion phase after rat liver ischemia [J ] . Transplan Proc , 1996 ; 28 (3)∶1908-1916
10. Kuo PC , Drachenberg CI , de la Torre A , et al . Apoptosis and hepatic allograft reperfusion injury [J ] . Clin Transplant , 1998 ; 12 (3)∶219-227
11. Jae-Sung,Lihua He,John J Lemasters.Mitochondrial permeability transition:a common pathway to necrosis and apoptosis [J ].Biochemical and Biophysical Research Communications.2003,304(3):463-470
12. Liu D, Lu C, Wan R et al,Activation of mitochondrial ATP-dependent potassiumchannels protects neurons against ischemia-induced death by a mechanisms involving suppression of Bax translocation and cytochrome c release, J. Cereb. Blood FlowMetab. 2002, 22 (4) : 431-433.
13. Fabio Di Lisa,Marcella Canton ,Roberta Menabo ,et al .Mitochondia and reperfusion injury–the role of permeability transition [J ].Basic Res Cardiol,2003,98(4):235-241
14. Kienle K, RentschM, Müller T, et al. Expression of Bcl-2 in liver grafts after adenoviral transfer improves survival following prolonged ischemia and reperfusion in rat liver transplantation [ J ]. Transp lant Proc,2005, 37: 439 - 441
1. Jaeschke H. Molecular mechanisms of hepatic ischemiareperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 2003;284:G15-26.
2. Tsujimoto, Y. Cell death regulation by the Bcl-2 protein family in the mitochondria. J.Cell. Physiol. 2003,195:158-167.
3. Carini R , Grazia M ,Splendore R ,et al. Sigal pathway invoved in the development of hypoxic preconditioning in rat hepatocytes. Hepatology ,2001 ,33 :131-139.
4.汪炜健刘荣国史春霞,等.二氮嗪预处理对缺氧复氧后大鼠海马神经元凋亡的影响.中华麻醉学杂志.2006,26(3):252-254
5. Tsouka V , Markou T , Lazou A. Differential effect of ischemic and pharmacological preconditioning on PKC isoform translocation in adult rat cardiac myocytes[J ] . Cell Physiol Biochem , 2002 ,12(5-6): 315-325
6. Carini R , De Cesaris MG, Splendore R ,et al . Ischemic precondition ingreduces Na ( + ) accumulation and cell killing in isolated rat hepatocytes exposed to hypoxia. Hepatology , 2000 , 31 : 166-172.
7. Carini R , Grazia M ,Splendore R ,et al. Sigal pathway invoved in the developement of hypoxic preconditioning in rat hepatocytes. Hepatology ,2001 ,33 :131-139.
8.杨红张文健吴练秋,等.ɑ-1抗胰蛋白酶对肝窦内皮细胞缺氧-复氧损伤保护作用的实验研究.中华医学杂志.2005,85(2):106-110
9. Iu S, Harvey PRC, Makowka L, Petrunka CN, Ilson RG,Strasberg SM. Markers of allograft viability in the rat.Relatinship between transplantation viability and liver function in the isolated perfused rat liver. Transplantation 1987;45:562-569.
10. Ardehali H ,O’Rourke B. Mitochondrial KATP channels in cell survival and death[J ] . J Mol Cell Cardiol ,2005 ;39 :7–16
11. Imahashi K,Nishimura T, Yoshioka J , et al. Role of intracellular Na + kinetics in p reconditioned rat heart[ J ]. Circ Res, 2001, 88 (11) : 1176-1182.
12. SamavatiL,MonickMM, Sanlioglu S, et al. Mitochondrial KATP channel openers activate the ERK kinase by an oxidant-dependent mechanism [ J ]. Am J Physiol Cell Physiol, 2002, 283 (1) : C273-C281.
13. McCully JD,Wakiyama H, Cowan DB, et al. Diazoxide amelioration of myocardial injury and mitochondrial damage during cardiac surgery [ J ]. Ann Thorac Surg, 2002, 74 (6) : 2138-2145.
14. Garlid K D,Paucek P,Yarov-Yarovoy V,et al.The mitochondrial KATP channel openers[J ].J Biol Chem.1996,271(15):8796-8799
15. Bolli R. The late p hase of preconditioning[J ] . Circ Res ,20 00 ,87 (11) :973-983
16. Jaeschke H. Molecular mechanisms of hepatic ischemia reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 2003;284:G15-26.
17. Sasaki H , Matsuno T , Tanaka N , et al . Activation of apoptosis during the reperfusion phase after rat liver ischemia [J ] . Transplan Proc , 1996 ; 28 (3)∶1908-1919
18. Kuo PC , Drachenberg CI , de la Torre A , et al . Apoptosis and hepatic allograft reperfusion injury [J ] . Clin Transplant , 1998 ; 12 (3)∶219-231
19. Jae-Sung,Lihua He,John J Lemasters.Mitochondrial permeability transition:a common pathway to necrosis and apoptosis [J ].Biochemical and Biophysical Research Communications.2003,304(3):463-470
20. Liu D, Lu C, Wan R et al,Activation of mitochondrial ATP-dependent potassium channels protects neurons against ischemia-induced death by a mechanisms involving suppression of Bax translocation and cytochrome c release, J. Cereb. Blood FlowMetab. 2002, 22 (4) : 431-433.
21. Fabio Di Lisa,Marcella Canton ,Roberta Menabo ,et al .Mitochondia and reperfusion injury–the role of permeability transition [J ].Basic Res Cardiol,2003,98(4):235-241
1. Selzner N, Rudiger H, Graf R, Clavien PA. Protective strategies against ischemic injury of the liver. Gastroenterology 2003;125:917-36.
2. Hendreson JM.Liver transplantation and rejection:an overview.Hepato–Gastroenterol 1999;46:1482-1484.
3. Pagliaro P, Gattullo D, Rastaldo R, et al. Ischemic p reconditioning: from the first to the second window of protection[ J ]. Life Sci , 2001, 69 (1) :1 - 15.
4. Tsujimoto, Y. Cell death regulation by the Bcl-2 protein family in the mitochondria. J.Cell. Physiol. 2003,195, 158-167 .
5. Kamada N, Calne RY. Surgical experience with five hundred thirty liver transplants in the rat[ J ]. Surgery, 1983, 93 (1 Pt 1) : 64 - 69.
6. Lewis DL, Hagstrom JE, Loomis AG, Wolf Ja, Herweijer H.Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nature Genet 2002;32:107-108.
7. Qian SG,Fung JJ,Demetris AJ,et al .Orthotopic liver transplantation in the mouse . Transplantation,1991,52:562-564
8. Ploeg RJ, D’Alessandro AM,Knechtle SJ,et al. Risk factors for primarydysfunction after liver transplantation--amultivariate analysis.Transplantation.1993;55(4): 807- 813.
9. Tian Y,Rudiger HA,Juchum W,et al .Comparison of arterialized and non arterialized orthotopic liver transplantation in mice . Transplantation,2002,74:1242-1246
10. Steger U,Sawjtzkj B,Gassel AM,et al.Impact of hepatic rearterialization on reperfusion injury and outcome after liver transplantation. Transplantation, 2003,76: 327-332
11.陈志宇,张玉君,王曙光等.小鼠原位肝移植模型的建立.中华实验外科杂志。2006,23(10):1261-1262
12. Hammond SM, Boettcher S, Caudy A A, et al. Argonaute , a link between genetic and biochemical analyses of RNAi [ J ]. Science, 2001, 293 (5532) : 1146-1150.
13. ZenderL, Hutker S, Liedtke C, et al. Caspase 8 small interfering RNA prevents acute liver failure in mice [ J ]. Proc Natl Acad SciUSA, 2003, 100 (13) : 7797-7802.
14. Layzer J M, McCaffreyA P, TannerA K, et al. In vivo activity of Nuclease resistantsiRNAs[ J ]. RNA, 2004, 10 (5) : 766-771.
15. Rusckowski, M., Ou, T., Roskey, A., and Agrawal, S. Biodistribution and metabolism of a mixed backbone oligonucleotide (GEM 231) following single and multiple dose adminstration in mice. Antisense Nucleic Acid Drug Dev. 2000. 10:333-345.
1. Selzner N, Rudiger H, Graf R, Clavien PA. Protective strategies against ischemic injury of the liver. Gastroenterology 2003;125:917-936.
2. Jaeschke H. Molecular mechanisms of hepatic ischemiareperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 2003;284:G15-26.
3. Fabio Di Lisa,Marcella Canton ,Roberta Menabo ,et al .Mitochondia and reperfusion injury–the role of permeability transition [J ].Basic Res Cardiol,2003,98(4):235-241.
4. Shigeomi Shimizu,Toku Kanaseki, Noboru Mizushima. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes Nature Cell Biology 2004:6:1221-1234
5. Ockaili R ,Emani VR ,Okubo S ,et al . Opening of mitochondrial KATPchannel induces early and delayed cardioprotective effect : role of nitricoxide[J ] . Am J Physiol Heart Circ Physiol , 1999 , 277 (6) : 2425 -2434.
6. Eckhoff DE, Bilbao G, Frenette L, Thompson JA, Contreras JL. 17-Beta-estradio protects the liver against warm ischemia/reperfusion injury and is associated with increased serum nitric oxide and decreased tumor necrosis factor-alpha. Surgery 2002;132:302-309
7. Beilharz E, Williams C, Dragunow M, Sirimanne E, Gluckman P. Mechanisms of delayed cell death following hypoxic-ischemic injury in the immature rat: evidence for apoptosis during selective neuronal loss. Brain Res Mol Brain Res 1995; 29: 1-6
8. Motoyama S, Minamiya Y, Saito S, et al. Hydrogen peroxide derived from hepatocytes induces endothelial cell apoptosis in perfused hypoxic rat liver. Gastroenterology 1998; 114: 153-164
9. Kohli, Vivek, Selzner,Markus,Madden, et al. Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion after ischemia-reperfusion injury in the rat liver. Transplantation. 1999, 67(8)27:1099-1105
10. Strasberg SM,Howard TK,Molmenti EP,et al.Selecting the doner liver:risk factors for poor function after orthotopic liver transplantation .Hepatology ,1994,20:829-837
11. Ito K, Ozasa H , Nagashima Y, et al . Pharmacological preconditioning with doxorubicin. Implications of heme oxygenase-1 induction in doxorubicin inducedhepatic injury in rats [ J ] . Biochem Pharmacol ,2001 ,62 (9) :1249-1255
12. Kume M ,Yamamoto Y,Yamagami K,et al. Pharmacological hepatic preconditioning : involvement of 70-kDa heat shock proteins (HSP72 and HSP73) in ischaemic tolerance after intravenous administration of doxorubicin[J ] .Br J Surg , 2000, 87 (9) :1168 -1175
13. Nilsson B , Friman S ,Wallin M ,et al . The liver protective effect of ischemic preconditioning may be mediated by adenosine [ J ] .Transpl Int ,2000 , 13 Suppl 1 :558 - 561
14. Harmeet Malhi ,Gorla , Irani , et al . Cell transplantation after oxidative hepatic preconditioning with radiation and ischemia-reperfusion leads to extensive liver repopulation [ J ] . Proc Natl Acad Sci USA ,2002 , 99 (20) : 13114 - 13119
15. Terajima H ,Enders G , Thiaener A , et al. Impact of hyperthermic preconditioning on postischemic hepatic microcirculatory disturbances in an isolated perfusion model of the rat liver [J ] . Hepatolgy ,2000 , 31 (2) :407-415
16. Marc ARC Daemen ,Heemskerk , Veer , et al. Functional protection by acute phase proteinsɑ1-acid glycoprotein and inflammation[J ] . Circulation ,2000 , 102 (12) : 1420
17. Ardehali H ,O’Rourke B. Mitochondrial KATP channels in cell survival and death[J ] . J Mol Cell Cardiol ,2005 ;39 :7-16
18. Hai S,Takemara S,Minamiyama Y,et al.Mitochondrial Katp channel opener prevents ischemia-reperfusion injury in rat liver [ J ] .Transplant Proc ,2005,37:428-431
19. Kohli V ,Selzner M,Maden JF , et al . Endothellal cell and hepatocyte death occur by apoptosis after ischemia-reperfusion injury in the rat liver[J] . Transplantation ,1999 ,67 (8) :1099-1105.
20. Sasaki H ,Matsuno T ,Tanaka N , et al . Induction of apoptosis during the early phase of reperfusion after rat liver ischemia[J ] . Acta Med Okayama ,1997 ,51(6) :305-312
21. Kuo PC ,Drachenberg CI ,de la Torre A , et al . Apoptosis and hepatic allograft reperfusion injury[J ] . Clin Transplant ,1998 ,12(3) :219-225
22. Kienle K, RentschM, Müller T, et al. Expression of Bcl-2 in liver grafts after adenoviral transfer improves survival following prolonged ischemia and reperfusion in rat liver transplantation [ J ]. Transp lant Proc,2005, 37: 439-441
23. Oltval Z ,Milliman C ,Korsmeyer S.Bcl-2 heterodimerizes in vivo with a conserved homolog, bax , that accelerates programmed cell death [ J ] .Cell ,1993 ,74(4) :609-619.
1. Morioka O , Kubota T , Sekido H , et al . Prostaglandin E1 improved the function of transplanted fatty liver in a rat reduced-size-liver transplantation model under conditions of permissible cold preservation[J ] .Liver Transpl , 2003 ,9 (1) :79-86.
2. Shah V , Kamath PS. Nitric oxide in liver transplantation : Pathobiology and clinical implications[J ] . Liver Transpl ,2003 ,9(1) :1-11.
3. Liu W,Schob O,Pugmire JE,et al.Glycohydrolases as markers of hepatic ischemia- reperfusion injury and recovery.Hepatology,1996,24(1):157-162.
4. Mizunuma K, Ohdan H , Tashiro H , et al . ROCK inhibitor Y-27632 prevents primary graft non-function caused by warm ischemia- reperfusion in rat liver transplantation[J ] . Transpl Int , 2002 ,15 (12) :623-629.
5. Khandoga A , Biberthaler P , Enders G, et al . P2selectin mediates platelet-endothelial cell interactions and reperfusion injury in the mouse liver in vivo[J ] . Shock ,2002 ,18 (6) :529-535.
6. DingWX, Yin XM. Dissection of themultiple mechanisms of TNF - alpha - induced apoptosis in liver injury [ J ]. J Cell Mol Med,2004, 8: 445 - 454.
7. NeumanMG. Apoptosis in diseases of the liver [ J ]. Crit Rev Clin Lab Sci, 2001, 38: 109-166.
8. XuWH, Ye QF, Xia SS. Apop tosis and p roliferation of intrahepatic bile duct after ischemia- reperfusion injury [ J ]. Hepatobiliary Pancreat Dis In, 2004, 3: 428 - 432.
9. J iang H, Meng F, Li J, et al. Anti - apoptosis effects of oxymatrine protect the liver from warm ischemia reperfusion injury in rats [ J ].World J Surg, 2005, 29: 1397 - 1401.
10. Alessenko AV, Galperin EI, Dudnik LB, et al.Role of tumor necrosis factor alpha and sphingomyelin cycle activation in the induction of apop tosis by ischemia / reperfusion of the liver[ J ]. Biochemistry, 2002, 67: 1347 - 1355.
11. Skulachev VP, Longo VD. Aging as a mitochondria - mediated atavistic p rogram: can aging be switched off [ J ] Ann N Y Acad Sci,2005, 1057: 145 - 164.
12. Chang EJ, Lee SH, Mun KC, et al. Effect of artificial cells on hepatic function afterischemia - reperfusion injury in liver [ J ]. Transplant Proc, 2004, 36: 1959 - 1961.
13. Peralta C, Xaus C, Bartrons R, et al. Effect of ozone treatment on reactive oxygen species and adenosine production during hepatic ischemia - reperfusion [ J ]. Free Radic Res,2000, 33: 595 - 605
14. Nakagawa T, Shimizu S, Watanabe T, et al.Cyclophilin D - dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death [ J ]. Nature, 2005,434: 652 - 658.
15. Kim JS, Qian T, Lemasters JJ. Mitochondrial permeability transition in the switch from necrotic to apoptotic cell death in ischemic rat hepatocytes [ J ]. Gastroenterology, 2003,124: 494 - 503.
16. Vilatoba M, Eckstein C, Bilbao G, et al.Sodium 4 - phenylbutyrate p rotects against liver ischemia reperfusion injury by inhibition of endoplasmic reticulum - stress mediated apoptosis [ J ]. Surgery, 2005, 138: 342- 351.
17. Kitano H, Nishimura H, Tachibana H, et al.ORP150 ameliorates ischemia / reperfusion injury from middle cerebral artery occlusion in mouse brain[ J ]. Brain Res, 2004, 1015: 122- 128.
18. ShibataM, Hattori H, Sasaki T, et al. Activation of caspase - 12 by endoplasmic reticulum stress induced by transient middle cerebral artery occlusion in mice [ J ]. Neuroscien, 2003, 118: 491 - 499.
19. MiyagawaY,Imamura H,Soeda J,et al .Fate of hepatocytes and sinusoidal lining cell function and kinetics after extended cold preservation and transplantation of rat liver .Liver Transpl,2002,8:370-381
20. Shinoda M, Shimazu M, Wakabayashi G, et al . Tumor necrosis factor suppression and microcirculatory disturbance amelioration in ischemia-reperfusion injury of rat liver after ischemic preconditioning [ J ] . JGastroenterol Hepatol , 2002 ,17 (11):1211-1219.
21. Harada H ,Wakabayashi G,Takayanagi A , et al . Transfer of the interleukin1 receptor antagonist gene into rat liver abrogates hepatic ischemia/reperfusion injury [ J ] . Transplantation , 2002 , 74 ( 10) : 1434-1441.
22.孙备,姜洪池细胞凋亡与缺血-再灌注损伤的研究进展[J ] .国外医学外科学分册,1998 ,25(6) :325-326.
23.孙备,姜洪池.肝移植供肝保护的研究进展[J ]国外医学外科学册,2000,27(3) :135-138.
24. Nilsson B, F riman S, Gustafsson B I, et al. Preconditioning protects against ischem ia/reperfusion injury of the liver [J ]. J Gastrointest Su rg. 2000,4 (1) : 44-49.
25. Sawaya DE J r, BrownM , M inardiA , et al. The role of ischemic preconditioning in the recruitment of rolling and adherent leukocytes in hepatic venules after ischemia/ reperfusion [ J ]. JS u rg R es. 1999 ; 85 (1) : 163-170.
26. Yin DP, Sankary HN , Chong A S, et al. P rotective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats[J ]. T ransplantation. 1998 ,27; 66 (2):152-157.
27. Schulz R, Gres P, Heusch G. Role of endogenous opioids in ischemic preconditioning but not in short-term hibernation in pigs[J ]. A m J P hy siol Heart Circ Physiol. 2001, 280 (5): 2175-2181.
28. Clavien PA , Yadav S, Sindram D, et al. P rotective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans [J ]. Ann Surg. 2000 , 232 (2) :155-162.
29. Clavien PA , Selzner M , Rudiger HA , et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic p reconditioning[J ],Ann Surg , 2003, 238: 843-852.
30. Chouker A , Schachtner T, Schauer R, et al. Effects of Pringlet manoeuvre and ischaem ic preconditioning on haemodynamic stability in patients undergoing elective hepatectomy: a randomized trial[J ]. Br J A naesth. 2004,93 (2) :204-211.
31. Li SQ , Liang LJ , Huang JF, et al. Ischemic preconditioning protects liver from hepatectomy under hepatic inflow occlusion for hepatocellular carcinoma patients with cirrhosis[J ]. W orld J Gastroenterol. 2004 , 10 (17) : 2580-2584.
32. Nuzzo G, Giuliante F, Vellone M , et al. Pedicle clamping with ischemic preconditioning in liver resection [ J ]. L iver T ranspl.2004 , 10 (2) : S53-57.
33. Singh AK,Mani H ,Seth P , et al . Picroliv preconditioning protects the rat live against ischemia-reperfusion injury[J ] . Eur J Pharmacol ,2000 ,395 (3) :229-239.
34. Wieland E ,Schutz E ,Armstrong VW, et al . Idebenone protects hepatic microsomes against oxygen radical-mediated damage in organ preservation solution[J ] . Transplantation ,1995 ,60(3) :444-451.
35. Klein M,Geoghegan J ,Wangemann R , et al . Preconditioning of donor livers with prostaglandin I2 before retrieval decreases hepatocellular ischemia-reperfusion injury [ J ] . Transplantation , 1999 , 67 ( 8) :1128-1132.
36. Merion RM. Prostaglandins in liver transplantation [ J ] . Adv ExpMed Biol, 1997, 433(1) :132-18.
37. Peralta C , Bulbena O ,Bargallo R , et al . Strategies to modulate the deleterious effects of endothelin in hepatic ischemia-reperfusion [J ] .Transplantation, 2000, 70(12): 1761- 1770.
38. Howell JG, Zibari GB ,Brown MF , et al . Both ischemic and pharmacological preconditioning decrease hepatic leukocytePendothelial cellinteractions [J ] . Transplantation, 2000 ,69 (2) :300-303.
39. Lee MH , Bae SK,Kim YG, et al . Dose-independent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage ,KR-31543 , after intravenous and oral administration to rats : Hepatic and intestinal first-pass effects[J ] . J Pharm Sci , 2003 ,92 (1) :190-201.
40. Glanemann M, Vollmar B , Nussler AK, et al . Ischemic preconditioning protects from hepatic ischemia- reperfusion injury by preservation of microcirculation and mitochondrial redox-state[J ] . J Hepatol ,2003 ,38 (1) :59-66.
41. Zhu XH ,Qiu YD ,Shen H ,et al. Effect of matrine on Kupffer cell activation in cold ischemia reperfusion injury of rat liver[J ] . World J Gastroenterol ,2002 ,8 :1112-1223
42. Schauer RJ ,Bilzer M ,Kalmuk S ,et al. Microcirculatory failure after rat liver transplantation is related to Kupffer cell derived oxidant stress but not involved in early graft dysfunction[J ] . Transplantation ,2001 ,72 :1692-1702
43. Charrueau CA , Carayon A , Thurman RG. Long-term cold liver storage induces endothelin-1 release and a time-dependent increase in portal pressure at reperfusion in the rat [J ] .J Gastroenterol ,2002 ,37 :717-721
44. Kume M ,Yamamoto Y,Yamagami K,et al. Pharmacological hepatic preconditioning : involvement of 702kDa heat shock proteins(HSP72 and HSP73) in ischemic tolerance after intravenous administration of doxorubicin [ J ] . Bri J Surg ,2000 ,87 :1168-1183
45. Fudaba Y, Ohsan H , Tashiro H , et al. Geranylger anylacetone ,a heat shock protein inducer ,prevents primary graft nonfunction in rat liver transplantation [ J ] .Transplantation ,2001 ,72 :184-193
46.苏东,李昆.抑肽酶预处理防护大鼠肝脏缺血再灌注损伤的实验研究[J ] .重庆医学, 2002 ,31 (8) :709-713
47.陈莉芬,胡长林.复方阿魏酸对实验性脑缺血再灌注损伤热休克蛋白70的作用[J ] .重庆医学,2002 ,31 (11) :1061-1067
48. Coito AJ ,Buelow R ,Shen XD ,et al. Heme oxygenase-1 gene transfer inhibits inducible nitric oxide synthase expression and protects genetically fat Zuker rat livers from ischemia-reperfusion injury[J ] . Transplantation ,2002 ,74 :96-105
49. Harada H ,Wakabayashi G, Takayanagi A ,et al. Transfer of the interleukin-1 receptor antagonist gene into rat liver abrogates hepatic ischemia-reperfusion injury [ J ] . Transplantation, 2002 ,74 :1434-1443
50. Ichihara T ,Komagata Y, Yang XL ,et al. Resistance to fulminant hepatitis and carcinogenesis conferred by overpression of retinoblastoma protein in mouse liver [ J ] . Hepatology ,2001 ,33 :948-957
51. Lehmann TG,Wheeler MD ,Schoonhoven R ,et al. Delivery of Cu/ Zn-superoxide dismutase genes with a viral vector minimizes liver injury and improves survival after liver trans plantation in the rat [J ] . Transplantation ,2000 ,69 :1051-1059
52. Levy MF ,Crippin J ,Sutton S ,et al. Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/hCD59) porcine livers[J ] . Transplantation, 2000, 69 :272-280
1. Bernstein E, CaudyA A, Hammond SM, et al. Role for a bidentate ribonuclease in the initiation step of RNA interference [ J ].Nature, 2001, 409 (6818) : 363-366.
2. Hammond SM, Bernstein E, Beach D, et al. An RNA-directed nuclease mediates post transcrip tional gene silencing in Drosophila cells[ J ]. Nature, 2000, 404 (6775) : 293-296.
3. Nykanen A, Haley B, Zamore P D. ATP requirements and small interfering RNA structure in the RNA interference pathway [ J ].Cell, 2001, 107 (3) : 309-321.
4. Fire A , Xu S , Montgomery MK, et al . Potent and specific genetic interference by dsRNA in caenorhabditis elegans [J ] . Nature ,1998 ,391 :806 - 811.
5. Caplen NJ , Fleenor J , Fire A , et al . DsRNA - mediated gene silencing in cultured Drosophila cells[J ] . Gene ,2000 ,252 :95 - 105.
6. Svoboda P ,Stein P , Hayashi H , et al . Selective reduction of dormant maternal mRNAs in mouse oocytes by RNA interference[J ] . Development ,2000 ,127 :4147 - 4156.
7. Zamore PD ,Tuschl T ,Sharp PA , et al . RNAi :dsRNA directs the ATP- dependent cleavage of mRNA at 21 to 23 nucleotide intervals [ J ] .Cell ,1999 ,101 :25 - 33.
8. Hommond SM . An RNA - directed nuclease mediates PTGS in Drosophila cells[J ] . Nature ,2000 ,404 :293 - 296.
9. Elbashir SM, Harbort H, Lendackel , et al . Duplexes of 21– nucleotide RNAs medate RNA interference in cultured mammalian cells [J ] . Nature ,2000 ,411 :494 - 498.
10. Hammond SM, Boettcher S, Caudy A A, et al. Argonaute 2, a link between genetic and biochemical analyses of RNAi [ J ]. Science, 2001, 293 (5532) : 1146-1150.
11. Takasaki S, Kawamura Y, Konagaya A. Selecting effective siRNA sequences based on the self2organizing map and statistical techniques[ J ]. Comput Biol Chem, 2006, 30 (3):169-178.
12. Russell P, Walsh E, ChenW, et al. The effect of temperature on gene silencing by siRNAs: Imp lications for silencing in the anterior chamber of the eye[ J ]. Exp Eye Res, 2006, 82 (6) : 1011-1016.
13. Martin S E, Cap len N J. Mismatched siRNAs downregulate mRNAs as a function oftarget site location [ J ]. FEBS Lett, 2006,580 (15) : 3694-3698.
14. Fraser AG. Fuctional genomic analysis of cell division in C elegans chrosome 1 by systematic RNAi [J ] . Nature ,2000 ,408 :325 - 330
15. Gonczy P ,Echeverri G, Oegema K, et al . Functional genomic analysis of cell division in C. elegans using RNAi of genes on chromosome III [J ] . Nature ,2000 ,408 :331 - 336.
16. Zhang C, Tang C, Liu X, et al. SiRNA-containing liposomesmodified with polyarginine effectively silence the targeted gene [ J ]. J Control Release, 2006, 112 (2) : 229-239.
17. Marschall P, Malik N, Larin Z. Transfer of YACs up to 2. 3Mb intact into human cells with polyethylenimine [ J ]. Gene Ther,1999, 6 (9) : 1634-1637.
18. Goula D, Benoist C, Mantero S, et al. Polyethylenimine-based intravenous delivery of transgenes to mouse lung [ J ]. Gene Ther,1998, 5 (9) : 1291-1295.
19. GodbeyW T, BarryM A, Saggau P, et al. Polyethylenimine-mediated transfection: a new paradigm for gene delivery[ J ]. J Biomed Mater Res, 2000, 51 (3) : 321-328.
20. Brus C, Kleemann E, AignerA, et al. Stabilization of oligonucleotide polyethylenimine comp lexes by freeze drying: physicochemical and biological characterization [ J ]. J Control Release, 2004,95 (1) : 119-131.
21. Hornung V, Guenthner,BillerM, Bourquin C, et al. Sequence-specific potent induction of IFN-αby short interfering RNA in p lasmacytoid dendritic cells through TLR7 [ J ]. Nat Med, 2005, 11(3) : 263-270.
22. Judge A D, Sood V, Shaw J R, et al. Sequence-dependent stimulation of the mammalian innate immune resonse by synthetic siRNA[J]. Nat Biotechnol, 2005, 23 (4) : 457-462.
23. Werth S, Urban Klein B, Dai L, et al. A low molecular weight fraction of polyethylenimine ( PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes [ J ]. J Control Release, 2006, 112 (2) : 257-270.
24. ReadM L, Singh S, Ahmed Z, et al. A versatile reducible polycation-based system for efficient delivery of a broad range of nucleicacids[J]. Nucleic Acids Res, 2005, 33 (9) : e86.
25. Martin S E, Cap len N J. Mismatched siRNAs downregulate mRNAs as a function of target site location [ J ]. FEBS Lett, 2006,580 (15) : 3694-3698.
26. Yin C, Xi L, Wang X, et al. Silencing heat shock factor 1 by small interfering RNA abrogates heat shock-induced cardiop rotection against ischemia-reperfusion injury inmice [ J ]. J Mol CellCardiol, 2005, 39 (4) : 681-689.
27. Hassani Z, Lemkine G F, Erbacher P, et al. Lipid-mediated siRNA delivery down-regulates exogenous gene exp ression in the mouse brain at picomolar levels[ J ]. J Gene Med, 2005, 7 ( 2) :198-207.
28. PalliserD, ChowdhuryD, WangQ Y, et al. An siRNA-based microbicide protectsmice from lethal herpes simp lex virus infection [ J ]. Nature, 2006, 439 (7072) : 89-94.
29. Dubey P K, Mishra V, Jain S, et al. Liposomesmodified with cyclic RGD peptide for tumor targeting[ J ]. J Drug Target, 2004, 12 (5) : 257-264.
30. Soutschek J, Akinc A, Bramlage B, et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs[J]. Nature, 2004, 432 (7014) : 173-178.
31. ThomasM, Lu J J, Ge Q, et al. Full deacylation of poly ethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung[ J ]. Proc Natl Acad Sci USA, 2005, 102 ( 16 ):5679-5684.
32. Hwa Kim S, Hoon Jeong J, Chul Cho K, et al. Target-specific gene silencing by siRNA plasmid DNA comp lexed with folatemodified polyethylenimine [ J ]. J Control Release, 2005, 104 ( 1 ) :223-232.
33. Song E, Zhu P, Lee S K, et al. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface recep tors [ J ].Nat Biotechnol, 2005, 23 (6) : 709-717.
34. Simeoni F, MorrisM C, Heitz F, et al. Peptide-based strategy for siRNA delivery into mammalian cells [ J ]. Methods Mol Biol,2005, 309: 251-260.
35. de Jonge J, Holtrop M, Wilschut J, et al. Reconstituted influenza virus envelopes as an efficient carrier system for cellular delivery of smallinterfering RNAs[ J ]. Gene Ther, 2006, 13 (5) : 400-411.
36. Inoue A, Takahashi KA, Mazda O, et al. Electro-transfer of small interfering RNA ameliorated arthritis in rats[ J ]. Biochem Biophys Res Commun, 2005, 336 (3) : 903-908.
37. Kim TW, Lee J H, He L, et al. Modification of professional antigen presenting cellswith small interfering RNA in vivo to enhance cancer vaccine potency[ J ]. Cancer Res, 2005, 65 (1) : 309-316.
38. ZenderL, Hutker S, Liedtke C, et al. Caspase 8 small interfering RNA prevents acute liver failure in mice [ J ]. Proc Natl Acad SciUSA, 2003, 100 (13) : 7797-7802.
39. Layzer J M, McCaffreyA P, TannerA K, et al. In vivo activity of nuclease-resistant siRNAs[ J ]. RNA, 2004, 10 (5) : 766-771.
40. Giladi H, Ketzinel Gilad M, Rivkin L, et al. Small interfering RNA inhibits hepatitis B virus replication in mice [ J ]. Mol Ther,2003, 8 (5) : 769-776.
41. Sen A, Steele R, Ghosh A K, et al. Inhibition of hepatitis C virus protein expression by RNA interference[ J ]. Virus Res, 2003, 96(122) : 27-35.
42. DuxburyM S, Matros E, Ito H, et al. Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer[ J ].Ann Surg, 2004, 240 (4) : 667-674.
43. Fire A. RNA - triggered gene silencing[J ] . TIG,1999 ,15 :358 - 361.
44. Elbashir SM, Harbort H , Lendackel , et al . Duplexes of 21 - nucleotide RNAs medate RNA interference in cultured mammalian cells [J ] . Nature ,2000 ,411 :494 - 498.
1. Selzner N, Rudiger H, Graf R, Clavien PA. Protective strategies against ischemic injury of the liver. Gastroenterology 2003;125:917-36.
2. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 2003;284:G15-26.
3. Borghi-Scoazec G, Scoazec JY, Durand F, Bernuau J, Belghiti J, Feldman J, Henin D, et al. Apotpsis after ischemiareperfusion in human liver allografts. Liver Transpl Surg 1997;3:407-15.
4. Kohli V, Selzner M, Madden JF, Bentley RC, Clavien PA. Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. Transplantation 1999;67:1099-105.
5. Clavien PA, Harvey PR, Strasberg SM. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation 1992;53:957-78.
6. Lentsch AB, Kato A, Yoshidome H, McMasters KM, Edwards MJ. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology 2000;32:169-73.
7. Lindsten T,Zong W X,Thompson CB.Defining the role of the Bcl-2 family of proteins in the nervous system.Neuroscientist 2005,ll(1):10-15.
8. Kis B,Rajapakse NC,Snipes JA,Nagy K,Horiguchi T,Busija DW.Diazoxide induces delayed preconditioning in cultured rat cortical neurons.J Neurochem 2003: 87(4): 969-980.
9. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124– 36.
10. Cohen MV, Baines CP, Downey JM. Ischemic preconditioning: from adenosine receptor to KATP channel. Annu Rev Physiol 2000;62:79–109.
11. Lim, K.H., Javadov, S.A., The effect of ischemic preconditioning, diazoxide and 5- hydroxydecanoate on rat heart mitochondrial volume and respiration.Journal of Physiology.2002,545, 961–974.
12. Hai S,Takemara S,Minamiyama Y,et al.Mitochondrial Katp channel opener preventsischemia-reperfusion injury in rat liver [ J ] .Transplant Proc ,2005,37:428-431
13. Iu S, Harvey PRC, Makowka L, Petrunka CN, Ilson RG,Strasberg SM. Markers of allograft viability in the rat.Relatinship between transplantation viability and liver function in the isolated perfused rat liver. Transplantation 1987;45:562-9.
14. Kuo PC , Drachenberg CI , de la Torre A , et al . Apoptosis and hepatic allograft reperfusion injury [J ] . Clin Transplant , 1998 ; 12 (3)∶219
15. Eliseev RA,Vanwinkle B,Rosier RN,Gunter TE.Diazoxide-mediated preconditioning against apoptosis involves activation of cAMP-response element-binding protein(CREB)and NFkappaB.J Biol Chem 2004;279(45):46748-46754.
16. Hetz C,Viae PA,Bombrun A,Rostovtseva TK,M ontessuit S,Hiver A,Schwarz M K,Church DJ,Korsmeyer SJ,Martinou JC.An tonsson B.Bax channel inhibitors prevent mitochondrion-mediated apoptosis and protect neurons in a model of global brain ischemia.J Biol Chem 2005;280(52):42960-42970.